A recent US study has revealed a potential role for fine particles secreted by the body in the onset of preeclampsia, in results that may pave the way for developing new therapeutic approaches targeting these molecules and limiting their impact on blood vessels.
Wright State University in the US clarified in a report published on its website two days ago that the study conducted by its researchers, and published in the scientific journal "Hypertension" last September, showed elevated levels of these molecules in the blood of women suffering from preeclampsia.
For her part, experiments indicated that lowering the levels of these molecules helped improve the performance of cells responsible for maintaining the integrity of blood vessels, suggesting that their elevation may contribute to the progression of the condition.
The researchers added that targeting these molecules and eliminating excess amounts could constitute a promising therapeutic approach in the future, rather than limiting treatment to managing the high blood pressure associated with preeclampsia.
The study emphasized that the results are still in their early stages, as the experiments were conducted in the laboratory, and researchers continue to study the possibility of developing safe treatments based on them that can be used during pregnancy.
These results contribute to expanding the understanding of mechanisms associated with preeclampsia and opening the door to new research to limit its risks to the mother and fetus.
Preeclampsia is known as a health condition that may affect a woman during pregnancy, usually after the twentieth week, and is accompanied by high blood pressure, which may affect vital organ functions in the mother, such as the kidneys and liver, as well as its potential effects on fetal growth.
Source: Syrian Arab News Agency (SANA)
Comments (0)